{"id":96933,"date":"2024-01-09T09:39:42","date_gmt":"2024-01-09T04:09:42","guid":{"rendered":"http:\/\/finservwealth.com\/cipla-shares-in-focus-after-cell-therapy-product-jv-with-kemwell-biopharma\/"},"modified":"2024-01-09T09:39:42","modified_gmt":"2024-01-09T04:09:42","slug":"cipla-shares-in-focus-after-cell-therapy-product-jv-with-kemwell-biopharma","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/cipla-shares-in-focus-after-cell-therapy-product-jv-with-kemwell-biopharma\/","title":{"rendered":"Cipla shares in focus after cell therapy product JV with Kemwell Biopharma"},"content":{"rendered":"<p> The JV business is being created with the intention of selling innovative cell treatment products in the EU, Japan, and the USA.<\/p><div id=\"finse-399224204\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/cipla-sharesfocus-after-cell-therapy-product-jvkemwell-biopharma_17392351.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The JV business is being created with the intention of selling innovative cell treatment products in the EU, Japan, and the USA. The JV business is being created with the intention of selling innovative cell treatment products in the EU, Japan, and the USA.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/cipla-sharesfocus-after-cell-therapy-product-jvkemwell-biopharma_17392351.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> The JV business is being created with the intention of selling innovative cell treatment products in the EU, Japan, and the USA.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/cipla-sharesfocus-after-cell-therapy-product-jvkemwell-biopharma_17392351.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The JV business is being created with the intention of selling innovative cell treatment products in the EU, Japan, and the USA. The JV business is being created with the intention of selling innovative cell treatment products in the EU, Japan, and the USA.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/cipla-sharesfocus-after-cell-therapy-product-jvkemwell-biopharma_17392351.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> The JV business is being created with the intention of selling innovative cell treatment products in the EU, Japan, and the USA.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-96933","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2023\/200x200\/C\/Cipla3_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/96933","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=96933"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/96933\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=96933"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=96933"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=96933"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}